-
(2E,4E,6Z,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenoic acid
-
ChemBase ID:
405
-
Molecular Formular:
C20H28O2
-
Molecular Mass:
300.43512
-
Monoisotopic Mass:
300.20893014
-
SMILES and InChIs
SMILES:
OC(=O)/C=C(/C=C/C=C(\C=C\C1=C(CCCC1(C)C)C)/C)\C
Canonical SMILES:
C/C(=C/C=C/C(=C/C(=O)O)/C)/C=C/C1=C(C)CCCC1(C)C
InChI:
InChI=1S/C20H28O2/c1-15(8-6-9-16(2)14-19(21)22)11-12-18-17(3)10-7-13-20(18,4)5/h6,8-9,11-12,14H,7,10,13H2,1-5H3,(H,21,22)/b9-6+,12-11+,15-8-,16-14+
InChIKey:
SHGAZHPCJJPHSC-ZVCIMWCZSA-N
-
Cite this record
CBID:405 http://www.chembase.cn/molecule-405.html
NAMES AND DATABASE IDS
NAMES AND DATABASE IDS
Names Database IDs
IUPAC name
|
(2E,4E,6Z,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenoic acid
|
|
|
IUPAC Traditional name
|
|
Brand Name
|
Panretin
|
Panretin Gel
|
Panretyn
|
Panrexin
|
Renova
|
Retin-A
|
Retin-A Micro
|
Vesanoid
|
|
|
Synonyms
|
Retinoic Acid
|
ALRT-1057
|
BAL4079
|
alitretinoin
|
9-cis-Retinoic acid
|
Alitretinoin
|
(2E,4E,6Z,8E)-3,7-Dimethyl-9-(2,6,6-trimethylcyclohex-1-enyl)nona-2,4,6,8-tetraenoic Acid
|
AGN 192013
|
ALRT 1057
|
LG 100057
|
LGD 100057
|
LGD 1057
|
NSC 659772
|
Panretin
|
Panretyn
|
Panrexin
|
9-cis-Retinoic Acid
|
9-cis-Tretinoin
|
9-cis-Retinoic acid
|
9-顺式维甲酸
|
9-顺式视黄酸
|
|
|
CAS Number
|
|
MDL Number
|
|
PubChem SID
|
|
PubChem CID
|
|
DATA SOURCES
DATA SOURCES
All Sources Commercial Sources Non-commercial Sources
CALCULATED PROPERTIES
CALCULATED PROPERTIES
JChem
ALOGPS 2.1
Acid pKa
|
4.996648
|
H Acceptors
|
2
|
H Donor
|
1
|
LogD (pH = 5.5)
|
4.392896
|
LogD (pH = 7.4)
|
2.6406298
|
Log P
|
5.0143676
|
Molar Refractivity
|
97.7908 cm3
|
Polarizability
|
36.17498 Å3
|
Polar Surface Area
|
37.3 Å2
|
Rotatable Bonds
|
5
|
Lipinski's Rule of Five
|
false
|
Log P
|
5.66
|
LOG S
|
-4.8
|
Solubility (Water)
|
4.77e-03 g/l
|
PROPERTIES
PROPERTIES
Physical Property
Safety Information
Pharmacology Properties
Product Information
Bioassay(PubChem)
Solubility
|
0.6 mg/L
|
Show
data source
|
Dimethyl Sulfoxide (25mg/ml)
|
Show
data source
|
Ethanol (25 mg/ml)
|
Show
data source
|
|
Apperance
|
Pale Yellow Solid
|
Show
data source
|
|
Melting Point
|
189-191°C
|
Show
data source
|
|
Hydrophobicity(logP)
|
4.2
|
Show
data source
|
|
Storage Condition
|
Amber Vial, -86°C Freezer
|
Show
data source
|
|
Storage Warning
|
Store Dry in Freezer at -20°C for up to 1 year; in Solution
|
Show
data source
|
|
European Hazard Symbols
|
Toxic (T)
|
Show
data source
|
|
MSDS Link
|
|
German water hazard class
|
3
|
Show
data source
|
|
Risk Statements
|
61-36/37/38
|
Show
data source
|
|
Safety Statements
|
53-26-36/37/39-45
|
Show
data source
|
|
GHS Pictograms
|
|
Show
data source
|
|
Show
data source
|
|
GHS Signal Word
|
Danger
|
Show
data source
|
|
GHS Hazard statements
|
H315-H319-H335-H360
|
Show
data source
|
|
GHS Precautionary statements
|
P201-P261-P305 + P351 + P338-P308 + P313
|
Show
data source
|
|
Personal Protective Equipment
|
Eyeshields, full-face particle respirator type N100 (US), Gloves, respirator cartridge type N100 (US), type P1 (EN143) respirator filter, type P3 (EN 143) respirator cartridges
|
Show
data source
|
|
Storage Temperature
|
-20°C
|
Show
data source
|
|
Gene Information
|
human ... RARA(5914), RARB(5915), RARG(5916), RXRA(6256), RXRB(6257), RXRG(6258)
|
Show
data source
|
|
Purity
|
≥98% (HPLC)
|
Show
data source
|
|
Certificate of Analysis
|
|
Empirical Formula (Hill Notation)
|
C20H28O2
|
Show
data source
|
|
DETAILS
DETAILS
DrugBank
Sigma Aldrich
TRC
DrugBank -
DB00523
|
Item |
Information |
Drug Groups
|
approved; investigational |
Description
|
An important regulator of gene expression during growth and development, and in neoplasms. Tretinoin, also known as retinoic acid and derived from maternal vitamin A, is essential for normal growth; and embryonic development. An excess of tretinoin can be teratogenic. It is used in the treatment of psoriasis; acne vulgaris; and several other skin diseases. It has also been approved for use in promyelocytic leukemia (leukemia, promyelocytic, acute). [PubChem] |
Indication |
For topical treatment of cutaneous lesions in patients with AIDS-related Kaposi's sarcoma. |
Pharmacology |
Alitretinoin (9-cis-retinoic acid) is a naturally-occurring endogenous retinoid indicated for topical treatment of cutaneous lesions in patients with AIDS-related Kaposi's sarcoma. Alitretinoin inhibits the growth of Kaposi's sarcoma (KS) cells in vitro. |
Affected Organisms |
• |
Humans and other mammals |
|
External Links |
|
|
Sigma Aldrich -
R4643
|
Packaging Sealed ampule Biochem/physiol Actions Ligand for both the retinoic acid receptor (RAR) and the retinoid X receptor (RXR) that act as transcription factors to regulate the growth and differentiation of normal and malignant cells. Other Notes Tandem Mass Spectrometry data independently generated by Scripps Center for Metabolomics is available to view or download in PDF. R4643.pdf Tested metabolites are featured on Scripps Center for Metabolomics METLIN Metabolite Database. To learn more, visit sigma.com/metlin. |
Toronto Research Chemicals -
R245000
|
An endogenous retinoic acid isomer, which is capable of binding to both retinoic acid receptors (RAR) and retinoid X receptors (RXR). A biologically active ligand for members of the RAR and RXR subfamilies, implying that it may play a critical role in r |
REFERENCES
REFERENCES
From Suppliers
Google Scholar
PubMed
Google Books
- • Allenby, G., et al.: Proc. Natl. Acad. Sci. U.S.A., 90, 30 (1993)
- • Heyman, R.A., et al.: Cell, 68, 397 (1992)
- • Levin, A.A., et al.: Nature, 355, 359 (1992)
- Searching...Please wait...
PATENTS
PATENTS
PubChem Patent
Google Patent